3% Cannabidiol (CBD) cream
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 3% Cannabidiol (CBD) cream, covering 2021-06-18 to 2021-06-18. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial [Phase 2, Phase 3]